<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04659148</url>
  </required_header>
  <id_info>
    <org_study_id>2712-2020</org_study_id>
    <nct_id>NCT04659148</nct_id>
  </id_info>
  <brief_title>Surgical and Oncological Outcomes in Patients With Ulcerative Colitis-associated Rectal Cancer</brief_title>
  <acronym>UC-RectalK</acronym>
  <official_title>Surgical and Oncological Outcomes in Patients With Ulcerative Colitis Associated Rectal Cancer: a Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective observational study to investigate the short-term surgical outcomes,&#xD;
      and long-term oncological outcomes of patients diagnosed with Ulcerative colitis and rectal&#xD;
      cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inflammatory Bowel Disease (IBD) is a risk factor for the development of colorectal cancer&#xD;
      (CRC). Despite improved targeted screening and timely prophylactic resection, up to 15% of&#xD;
      all IBD-related mortality can be attributed to CRC.&#xD;
&#xD;
      Previous reports suggest that IBD patients present with CRC at an earlier age and with more&#xD;
      advanced disease than those with sporadic CRC. The literature is limited, however, with&#xD;
      respect to colitis-associated rectal cancer (CARC), which has unique considerations such as&#xD;
      surgical approach and the use of neoadjuvant therapy. Although total proctocolectomy is&#xD;
      generally the procedure of choice for those with CARC, recent reports reported acceptable&#xD;
      oncological outcomes after ileal pouch-anal anastomosis (IPAA) and ileorectal anastomosis&#xD;
      (IRA).&#xD;
&#xD;
      The impact of the type of surgical procedure on the oncologic outcome in patients with CARC&#xD;
      is not well defined.&#xD;
&#xD;
      The aim of this study is to investigate short-term surgical outcomes (postoperative&#xD;
      complications at 30 days after surgery) and long-term oncological outcomes (disease-free&#xD;
      survival) of CARC patients undergoing different surgical approaches.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical outcome</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>30 days postoperative complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oncological outcome</measure>
    <time_frame>5 years after surgery</time_frame>
    <description>Disease-free survival</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Rectal Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total proctocolectomy</intervention_name>
    <description>Total proctocolectomy: surgical removal of the colon, rectum, and anus</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will include adult patients with a proven diagnosis of Ulcerative Colitis and&#xD;
        rectal adenocarcinoma, who underwent intestinal resection for curative intent, in elective&#xD;
        or emergent setting, in the period between January 2004 and January 2020.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with Ulcerative Colitis;&#xD;
&#xD;
          -  Patients diagnosed with rectal cancer (within 15 cm from the anal verge);&#xD;
&#xD;
          -  Patients who underwent surgery for rectal cancer between January 2004 and January&#xD;
             2020;&#xD;
&#xD;
          -  All type of surgery will be included;&#xD;
&#xD;
          -  Surgery in elective and emergency settings.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients aged&lt;18 years;&#xD;
&#xD;
          -  Patients with a diagnosis of undetermined colitis;&#xD;
&#xD;
          -  Insufficient follow-up data.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonino Spinelli, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Clinico Humanitas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annalisa Maroli</last_name>
    <phone>+390282247776</phone>
    <email>annalisa.maroli@humanitas.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <state>MI</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Humanitas R Hospital</last_name>
      <phone>0282247776</phone>
      <email>annalisa.maroli@humanitas.it</email>
    </contact>
    <contact_backup>
      <phone_ext>Spinelli</phone_ext>
      <email>antonino.spinelli@humanitas.it</email>
    </contact_backup>
    <investigator>
      <last_name>Antonino Spinelli, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michele Carvello, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Mark's Hospital</name>
      <address>
        <city>Harrow</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vittoria Bellato, MD</last_name>
      <phone>(0)20 8864 3232</phone>
      <phone_ext>+44</phone_ext>
      <email>vittoria.bellato@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Janindra Warusavitarne, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vittoria Bellato, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 2, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2020</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ulcerative Colitis</keyword>
  <keyword>Rectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

